TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14902 · Jul 3

#go#tailscale#tailscale_control_server#tailscale_server#wireguard Headscale is an open-source, self-hosted alternative to the Tailscale control server, letting you create your own private VPN network using Wireguard technology. It supports key Tailscale features like node registration, DNS, file sharing (Taildrop), access control lists (ACLs), and more, making it ideal for personal or small group use. By running Headscale yourself, you gain full control over your network without relying on Tailscale’s servers, enhancing privacy and customization. You can manage access precisely with ACLs, tag devices for group policies, and use modern VPN benefits like NAT traversal and secure connections between your devices[1][3][5]. This helps you securely connect and control your devices in a private network tailored to your needs. https://github.com/juanfont/headscale

Results

4 similar posts found

Search: #vets

当前筛选 #vets清除筛选
VetPlus Academy

@vetplusacademy · Post #1291 · 01/29/2026, 03:42 PM

¡Tu crecimiento profesional no se detiene! 📈 Estamos diseñando un espacio donde la teoría y la práctica se encuentran para fortalecer tus competencias clínicas. Guías descargables, sesiones en vivo y certificación mensual son solo el comienzo. Mantente conectado. Lo que viene superará tus expectativas ✨ 🌐 Visítanos: vetplusacademy.com 📲 WhatsApp: +58 414 5300397 #VetPlus#Vets#MedVet#EstudiantesVeterinaria#VetPlusUltra

VET's HUB ®

@vets_hub · Post #30255 · 12/07/2025, 03:32 AM

NEWS 🔻𝗪𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗱𝗿𝘂𝗴𝘀 𝗳𝗼𝗿 𝗰𝗮𝘁𝘀? 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝘀 𝗶𝗻 𝗰𝗮𝘁𝘀 #Okava_Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new #GLP_1 clinical weight loss study for cats. #MEOW_1, as the study is called, will look to use #OKV_119, a miniature implant, in cats which will deliver the GLP-1, continuously for up to six months. According to #Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets. Klotsman said the goal would be to file for #FDA approval for the product between 2027 and 2028, and the target is for the product to cost owners an out-of-pocket payment of around $100 per month. Read the full story 👇 https://abcnews.go.com/GMA/Wellness/weight-loss-drugs-cats-company-launches-clinical-trial/story?id=128054236 #feline#cats#pets#petobesity#petcare#okavapharmaceuticals#sanfrancisco#vets#petowners#veterinarians#dvm